One article reviewed the literature of all published male LAM cases from April 1986 to October 2021 and statistically showed that the positivity rates of HMB-45, SMA, Desmin, and estrogen receptor in immunohistochemistry were approximately 40%, 76%, 89%, and 16%, respectively (20). This evidence concerns the gene ESR1 and lymphangioleiomyomatosis.